Baker Julian's Form 4 filing
Neurogene Inc. (NGNE) · filed Aug 17, 2023
- Accession no.
- 0001209191-23-046351
- Filed
- Aug 17, 2023, 5:08 PM ET
- Trade date
- Aug 15-17, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 12 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker JulianCIK 0001087939 | Director, 10% Owner |
| Baker FelixCIK 0001087940 | Director, 10% Owner |
| Baker Bros. Advisors LPCIK 0001263508 | Director, 10% Owner |
| Baker Brothers Life Sciences LPCIK 0001363364 | Director, 10% Owner |
| 667, L.P.CIK 0001551139 | Director, 10% Owner |
| Baker Bros. Advisors (GP) LLCCIK 0001580575 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | PPurchaseAcquired | +143,519 | $0.6308 | +$90,531.79 | 463,568 | Indirect | |
| Aug 15, 2023 | Common Stock | PPurchaseAcquired | +1,740,581 | $0.6308 | +$1,097,958.49 | 5,242,272 | Indirect | |
| Aug 15, 2023 | Common Stock | PPurchaseAcquired | +358 | $0.665 | +$238.07 | 463,926 | Indirect | |
| Aug 15, 2023 | Common Stock | PPurchaseAcquired | +4,342 | $0.665 | +$2,887.43 | 5,246,614 | Indirect | |
| Aug 16, 2023 | Common Stock | PPurchaseAcquired | +17,124 | $0.6805 | +$11,652.88 | 481,050 | Indirect | |
| Aug 16, 2023 | Common Stock | PPurchaseAcquired | +207,676 | $0.6805 | +$141,323.52 | 5,454,290 | Indirect | |
| Aug 16, 2023 | Common Stock | PPurchaseAcquired | +366 | $0.6828 | +$249.9 | 481,416 | Indirect | |
| Aug 16, 2023 | Common Stock | PPurchaseAcquired | +4,434 | $0.6828 | +$3,027.54 | 5,458,724 | Indirect | |
| Aug 17, 2023 | Common Stock | PPurchaseAcquired | +7,676 | $0.6924 | +$5,314.86 | 489,092 | Indirect | |
| Aug 17, 2023 | Common Stock | PPurchaseAcquired | +93,091 | $0.6924 | +$64,456.21 | 5,551,815 | Indirect | |
| Aug 17, 2023 | Common Stock | PPurchaseAcquired | +5,041 | $0.6928 | +$3,492.4 | 494,133 | Indirect | |
| Aug 17, 2023 | Common Stock | PPurchaseAcquired | +61,134 | $0.6928 | +$42,353.64 | 5,612,949 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.